Evidence map›Paper›PMID 33544274›Full record

ArticleCellular and molecular neurobiology2022

The Characterization of Sex Differences in Hypoglycemia-Induced Activation of HPA Axis on the Transcriptomic Level.

Serpil Taheri, Zuleyha Karaca, Minoo Rassoulzadegan, Ecmel Mehmetbeyoglu, Gokmen Zararsiz, Elif Funda Sener, Kezban Korkmaz Bayram, Esra Tufan, Mustafa Caglar Sahin, Mert Kahraman Marasli and 6 more

Open access · greenAbstract read
In one paragraph

Article in Cellular and molecular neurobiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 3 countries.

Serpil TaheriBetul Ziya Eren Genome and Stem Cell Center, Erciyes University, Kayseri, Turkey.ORCID http://orcid.org/0000-0001-5806-8241
Zuleyha KaracaDepartment of Endocrinology, Erciyes University Medical School, Kayseri, Turkey.ORCID http://orcid.org/0000-0003-3241-2352
Minoo RassoulzadeganUniversité Côte D'Azur, CNRS, Inserm, France.ORCID http://orcid.org/0000-0002-5522-0647
Ecmel MehmetbeyogluDepartment of Cancer and Genetics, Cardiff University, Cardiff, UK.ORCID http://orcid.org/0000-0002-4597-6811
Gokmen ZararsizDepartment of Biostatistics, Erciyes University Medical School, Kayseri, Turkey.ORCID http://orcid.org/0000-0001-5801-1835
Elif Funda SenerBetul Ziya Eren Genome and Stem Cell Center, Erciyes University, Kayseri, Turkey.ORCID http://orcid.org/0000-0002-5644-5442
Kezban Korkmaz BayramBetul Ziya Eren Genome and Stem Cell Center, Erciyes University, Kayseri, Turkey.ORCID http://orcid.org/0000-0002-1228-1298
Esra TufanBetul Ziya Eren Genome and Stem Cell Center, Erciyes University, Kayseri, Turkey.ORCID http://orcid.org/0000-0003-3782-9085
Mustafa Caglar SahinBetul Ziya Eren Genome and Stem Cell Center, Erciyes University, Kayseri, Turkey.ORCID http://orcid.org/0000-0002-5141-8154
Mert Kahraman MarasliBetul Ziya Eren Genome and Stem Cell Center, Erciyes University, Kayseri, Turkey.ORCID http://orcid.org/0000-0002-1894-3731
Mehmet MemisBetul Ziya Eren Genome and Stem Cell Center, Erciyes University, Kayseri, Turkey.ORCID http://orcid.org/0000-0001-8505-4953
Halit CanatanDepartment of Medical Biology, Erciyes University Medical School, Kayseri, Turkey.ORCID http://orcid.org/0000-0002-0978-8311
Figen OzturkDepartment of Pathology, Erciyes University Medical School, Kayseri, Turkey.ORCID http://orcid.org/0000-0001-6180-5716
Fatih TanriverdiDepartment of Endocrinology, Erciyes University Medical School, Kayseri, Turkey.ORCID http://orcid.org/0000-0001-8277-6774
Kursad UnluhizarciDepartment of Endocrinology, Erciyes University Medical School, Kayseri, Turkey.ORCID http://orcid.org/0000-0003-2024-7433
Fahrettin KelestimurDepartment of Endocrinology, Yeditepe University Medical School, Istanbul, Turkey. fktimur@erciyes.edu.tr.ORCID http://orcid.org/0000-0002-2861-4683
Erciyes University · TRCardiff University · GBCentre National de la Recherche Scientifique · FRYeditepe University · TR

Funding

Türkiye Bilimsel ve Teknolojik Araştirma Kurumu 114S478
6 · The paper itself

Abstract

Activation of the hypothalamic-pituitary-adrenal (HPA) axis using an insulin tolerance test (ITT) is a medical diagnostic procedure that is frequently used in humans to assess the HPA and growth-hormone (GH) axes. Whether sex differences exist in the response to ITT stress is unknown. Thus, investigations into the analysis of transcripts during activation of the HPA axis in response to hypoglycemia have revealed the underlying influences of sex in signaling pathways that stimulate the HPA axis. We assessed four time points of ITT application in Balb/c mice. After insulin injection, expression levels of 192 microRNAs and 41 mRNAs associated with the HPA, GH and hypothalamic-pituitary-gonadal (HPG) axes were determined by real-time RT-PCR in the hypothalamus, pituitary and adrenal tissues, as well as blood samples (Raw data accession: https://drive.google.com/drive/folders/10qI00NAtjxOepcNKxSJnQbJeBFa6zgHK?usp=sharing ). Although the ITT is commonly used as a gold standard for evaluating the HPA axis, we found completely different responses between males and females with respect to activation of the HPA axis. While activation of several transcripts in the hypothalamus and pituitary was observed after performing the ITT in males within 10 min, females responded via the pituitary and adrenal immediately and durably over 40 min. Additionally, we found that microRNA alterations precede mRNA responses in the HPA axis. Furthermore, robust changes in the levels of several transcripts including Avpr1b and Avpr2 observed at all time points strongly suggest that transcriptional control of these genes occurs mostly via differential signaling in pituitary and blood between males and females. Male and female HPA axis responses to ITT involve a number of sophisticated regulatory signaling pathways of miRNAs and mRNAs. Our results highlight the first robust markers in several layers of HPA, HPG and GH axis involved in ITT/hypoglycemia stress-induced dynamics.

Indexed as

Human Growth HormoneHypoglycemiaAnimalsFemaleHypothalamo-Hypophyseal SystemInsulinMaleMicePituitary-Adrenal SystemSex CharacteristicsTranscriptomeHuman Growth HormoneInsulinGrowth hormone (GH) axisHypothalamic–pituitary–adrenal (HPA) axisHypothalamic–pituitary–gonadal (HPG) axisInsulin tolerance test (ITT)MicemiRNAsSex differencesTranscript profile

Identifiers

PMID33544274
PMCPMC11421699
OpenAlexW3127764127

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.